IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

The purpose of this study is to evaluate the safety and efficacy of IVIG in the treatment of metastatic cancer of the prostate, colon and melanoma.

Phase 2

GammaCan